Clinical Trial Update: Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 trial evaluating treatment of prolonged uterine bleeding associated with the etonogestrel-releasing implant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding
• Breakthrough Bleeding
• Prolonged Uterine Bleeding

Drugs mentioned

• Nexplanon (etonogestrel-releasing implant) (etonogestrel-releasing implant)

Snippet

Sponsor: University of Sao Paulo | Conditions: Breakthrough Bleeding | Phase 4 | Status: COMPLETED